Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inabata
Tokyo, Tokyo, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
Inabata is a long-standing, globally active Japanese trading company with a major pharmaceutical supply business, focusing on regulatory services and active pharmaceutical ingredient (API) manufacturing and distribution, and custom fine chemical manufacturing for pharma clients. There is no evidence from available sources of proprietary clinical-phase drug development or clinical trial results[1][2][4].
- Modalities
- Active pharmaceutical ingredientsSmall molecule (as APIs)Advanced intermediates
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Inabata.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inabata.